Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions
Randomized, Non-blind, 4-fold Crossover Study on Safety, Tolerability and Pharmacokinetics of Nifedipine After Single Oral Doses of Adalat® LA 60 mg or of a Marketed Generic Version of Nifedipine Retard 60 mg After an Overnight Fasting or Immediately After a High-fat American Breakfast in Healthy Male Volunteers
Bioavailability, Therapeutical Indication Not Studied